<DOC>
	<DOC>NCT02832570</DOC>
	<brief_summary>Efffect of a single dose oral intake of sildenafil Or placebo on the walking capacity on treadmill of PAD patients with claudication</brief_summary>
	<brief_title>Sildenafil Efficacy Study on Time Walk From Peripheral Arterial Desease Patients (Stade II) With Arterial Claudication</brief_title>
	<detailed_description>Sildenafil 100mg or Placebo Oral intake 2 hours before the treadmill test Safety and security control throughout the period of drug efficacy (approx 4 hours) Evaluation of maximal walking distance for a constant load treadmill test (3.2 kml/h 10% slope)</detailed_description>
	<mesh_term>Arterial Occlusive Diseases</mesh_term>
	<mesh_term>Peripheral Arterial Disease</mesh_term>
	<mesh_term>Sildenafil Citrate</mesh_term>
	<criteria>Patient with peripheral arterial desease stade II Patient with vascular claudication for at least 3 months Patient able to perform a treadmill walking test with time to walk &lt; 5min Patient suffering from ischemia Previous angina or myocardial Patient treated with nitrates drugs Patient with severe renal insufficiency Patient with severe hepatic insufficiency Patient with hypotension</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2016</verification_date>
</DOC>